What is are the health and economic impacts of declining vaccination rates?

VaxImpactMap is an interesting online tool that quantifies the health and economic costs of declining childhood vaccination. The tool was developed by Mahmud Sheku, Connor Van Meter, Robert Bednarczyk, and Ben Lopman at Emory University Rollins School of Public Health. The tool focuses on changes these outcomes for three vaccine preventable diseases: Rotavirus, Pertussis (Whooping…

Read More

RFK Jr. Faces Senate Finance Committee: A Live Discussion 

Health and Human Services Secretary Robert F. Kennedy Jr.’s testimony before the Senate Finance Committee follows the ouster last week of the director of the Centers for Disease Control and Prevention, Susan Monarez. At least four other senior CDC officials resigned in protest. What are the biggest takeaways? What comes next? Tune in for a…

Read More

4 Things Startups Must Know to Achieve a Successful Tech Pilot

In recent years, providers have been increasingly conducting tech pilots to see which solutions can best improve their clinical and operation success. During a panel at MedCity News’ INVEST Digital Health conference in Dallas, healthcare leaders shared their insight on how startups can best serve their provider partners during these pilots. The post 4 Things…

Read More

Why Hospitals’ Revenue Growth Is Likely to Slow Down in 2025

Hospitals’ operating margins dropped in November due to decreased patient demand levels and continued increases in expenses, according to a new report. One healthcare expert noted that rising expenses will remain a major problem for hospitals throughout 2025. The post Why Hospitals’ Revenue Growth Is Likely to Slow Down in 2025 appeared first on MedCity…

Read More

Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline

Repare Therapeutics is cutting discovery and preclinical work to focus on its clinical-stage cancer drugs. The most advanced program is camonsertib, whose rights Repare recently regained from Roche after the pharma giant terminated an alliance started in 2022. The post Cancer Biotech Repare Therapeutics Restructures to Focus on Clinical-Stage Pipeline appeared first on MedCity News.

Read More